Susquehanna International Group, LLP Rocket Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$20.66 - $26.72 $237,590 - $307,280	11,500 New	11,500 $247,000
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $199,682 - $380,086	-11,900 Reduced 43.43%	15,500 $464,000
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $241,120 - $384,800	-16,000 Reduced 36.87%	27,400 $561,000
Q2 2023 Aug 11, 2023	BUY	$16.59 - $23.6 $386,547 - $549,880	23,300 Added 115.92%	43,400 $862,000
Q1 2023 May 16, 2023	BUY	$15.79 - $22.6 $96,319 - $137,860	6,100 Added 43.57%	20,100 $344,000
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $60,450 - $88,764	3,900 Added 38.61%	14,000 $273,000
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $124,936 - $185,941	10,100 New	10,100 $161,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $890M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.